{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T07:17:49Z","timestamp":1775373469986,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.lfs.2016.11.001","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T20:31:02Z","timestamp":1478205062000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Assessment of the pharmacokinetic profile of novel s-triazine derivatives and their potential use in treatment of Alzheimer's disease"],"prefix":"10.1016","volume":"168","author":[{"given":"Jovana","family":"Trifunovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladan","family":"Bor\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u0161a","family":"Vukmirovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momir","family":"Mikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.lfs.2016.11.001_bb0005","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/1071576021000049890","article-title":"Amyloid beta-peptide1-42-induced oxidative stress and neurotoxicity: implication for neurodegeneration in Alzheimer's disease brain. A review","volume":"36","author":"Butterfield","year":"2002","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.lfs.2016.11.001_bb0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.arr.2015.07.002","article-title":"Slowing the progression of Alzheimer's disease; what works?","volume":"23","author":"Nelson","year":"2015","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2016.11.001_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jfma.2015.04.001","article-title":"Review article: current and novel therapeutic molecules and targets in Alzheimer's disease","volume":"115","author":"Kumar","year":"2016","journal-title":"J. Formos. Med. Assoc."},{"issue":"4","key":"10.1016\/j.lfs.2016.11.001_bb0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4155\/fmc.13.212","article-title":"Privileged s-triazines: structure and pharmacological applications","volume":"6","author":"Shah","year":"2014","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2016.11.001_bb0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/1389557513666140103111017","article-title":"1,2,3-Triazine scaffold as a potent biologically active moiety: a mini review","volume":"14","author":"Kumar","year":"2014","journal-title":"Mini-Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2016.11.001_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2011.554793","article-title":"A review of epidemiologic studies of triazine herbicides and cancer","volume":"41","author":"Sathiakumar","year":"2011","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.lfs.2016.11.001_bb0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0223-5234(89)90171-2","article-title":"Synthesis and cardiotonic activity of 2,4-diamino-1.3,5-triazines","volume":"24","author":"Kosary","year":"1989","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2016.11.001_bb0040","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/mrc.1260290511","article-title":"Sites of protonation in cardiotonic polyazaindolizines by NMR spectroscopy","volume":"29","author":"Barraclough","year":"1991","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.lfs.2016.11.001_bb0045","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4155\/fmc.12.57","article-title":"Antimicrobial, anti-TB, anticancer and anti-HIV evaluation of new s-triazine-based heterocycles","volume":"4","author":"Patel","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.lfs.2016.11.001_bb0050","first-page":"584","article-title":"Anti-HIV activity of some non-nucleoside s-triazine derivatives (part-IV)","volume":"34","author":"Desai","year":"1996","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.lfs.2016.11.001_bb0055","first-page":"1707","article-title":"Toxicity and anticancer activity of a new triazine antifolate","volume":"42","author":"Corbett","year":"1982","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.lfs.2016.11.001_bb0060","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1021\/acschemneuro.5b00121","article-title":"3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the first dual BACE-1\/GSK-3\u03b2 fragment hits against Alzheimer's disease","volume":"6","author":"Prati","year":"2015","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2016.11.001_bb0065","first-page":"8","article-title":"The neuroprotective effect of a triazine derivative in an Alzheimer's rat model","volume":"53","author":"Alipour","year":"2015","journal-title":"Acta Med. Iran."},{"key":"10.1016\/j.lfs.2016.11.001_bb0070","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1021\/ja01151a001","article-title":"Cyanuric chloride derivatives. I. Aminochloro-s-triazines","volume":"73","author":"Thurston","year":"1951","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.lfs.2016.11.001_bb0075","first-page":"1203","article-title":"RP-HPTLC retention data in correlation with the In-silico ADME properties of a series of s-triazine derivatives","volume":"13","author":"Jevric","year":"2014","journal-title":"Iran J. Pharm. Res."},{"key":"10.1016\/j.lfs.2016.11.001_bb0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.lfs.2016.11.001_bb0085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/0929867033368268","article-title":"Chromatographic retention parameters in medicinal chemistry and molecular pharmacology","volume":"10","author":"Nasal","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.lfs.2016.11.001_bb0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.steroids.2004.11.002","article-title":"HPTLC chromatography of androstene derivates. Application of normal phase thin-layer chromatographic retention data in QSAR studies","volume":"70","author":"Peri\u0161i\u0107-Janji\u0107","year":"2005","journal-title":"Steroids"},{"key":"10.1016\/j.lfs.2016.11.001_bb0095","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1021\/mp100373d","article-title":"Reversed-phase TLC and HPLC retention data in correlation studies with in silico molecular descriptors and druglikeness properties of newly synthesized anticonvulsant succinimide derivatives","volume":"8","author":"Peri\u0161i\u0107-Janji\u0107","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.lfs.2016.11.001_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.lfs.2016.11.001_bb0105","first-page":"899","article-title":"Prediction of in silico ADME properties of 1,2-O-isopropylidene aldohexose derivatives","volume":"13","author":"Kova\u010devi\u0107","year":"2014","journal-title":"Iran. J. Pharma. Scien."},{"key":"10.1016\/j.lfs.2016.11.001_bb0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejps.2013.01.018","article-title":"RP TLC data in correlation studies with in silico pharmacokinetic properties of benzimidazole and benztriazole derivatives","volume":"49","author":"Milosevic","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2016.11.001_bb0115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0959-440X(96)80061-3","article-title":"Computational methods for biomolecular docking","volume":"6","author":"Lengauer","year":"1996","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2016.11.001_bb0120","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/BF00123667","article-title":"A fast and efficient method to generate biologically relevant conformations","volume":"8","author":"Klebe","year":"1994","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"5","key":"10.1016\/j.lfs.2016.11.001_bb0125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/ane.12386","article-title":"Donepezil across the spectrum of Alzheimer's disease: dose optimization and clinical relevance","volume":"131","author":"Lee","year":"2015","journal-title":"Acta Neurol. Scand."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516306324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516306324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T10:15:58Z","timestamp":1718878558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320516306324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":25,"alternative-id":["S0024320516306324"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2016.11.001","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the pharmacokinetic profile of novel s-triazine derivatives and their potential use in treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2016.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}